Cannabix Technologies Provides Update Regarding COVID-19

Vancouver, British Columbia, March 24, 2020 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company and its staff remain operational at our labs in Vancouver, B.C. and Gainesville, Florida. The Company is closely monitoring the COVID-19 pandemic and has implemented additional measures at its lab locations to help safeguard the health of its staff while continuing to operate effectively. The Company has also begun preparations if further measures are implemented by governments in the coming days and weeks ahead.  These preparations would allow company staff to continue operations remotely if needed. The Company has experienced some temporary delays in parts shipments from some suppliers during the month of February, however orders have been arriving at normal levels since early March. Furthermore, the Company is taking additional safety measures during breath testing with its devices. 
 
In addition, Company engineers have been progressing development of its THC Breath Analyzer (“THCBA”) which incorporates microfluidic (MF) sensor technology for the detection of ∆9-tetrahydrocannabinol (“THC”) from breath. Over the course of February and March, engineers have been improving breath sample chamber design, incorporating additional sensors, improving the MF sensor design, improving battery life, enhancing circuitry and making changes to the form factor (exterior) design of the THCBA for better handling.